{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:38:30Z","timestamp":1773099510021,"version":"3.50.1"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"65","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,12]]},"DOI":"10.18632\/oncotarget.22668","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T16:31:13Z","timestamp":1511800273000},"page":"109258-109270","source":"Crossref","is-referenced-by-count":3,"title":["Induction of renal artery hyperresponsiveness by alpha1-adrenoceptor in hepatorenal syndrome"],"prefix":"10.18632","volume":"8","author":[{"given":"Xiaogang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinsen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yina","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyu","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi\u2019an 710061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,11,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Krag","year":"2010","journal-title":"Hepatology"},{"key":"2","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.3748\/wjg.v18.i36.4978","article-title":"Hepatorenal syndrome","volume":"18","author":"Lata","year":"2012","journal-title":"World J Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/SMJ.0b013e3181e07751","article-title":"Hepatorenal syndrome","volume":"103","author":"Venkat","year":"2010","journal-title":"South Med J"},{"key":"4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Arroyo","year":"2014","journal-title":"Hepatology"},{"key":"5","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1007\/s10620-016-4313-0","article-title":"Rifaximin decreases the incidence and severity of acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"61","author":"Te","year":"2016","journal-title":"Dig Dis Sci"},{"key":"6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12072-017-9784-3","article-title":"Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome","volume":"11","author":"Arroyo","year":"2017","journal-title":"Hepatol Int"},{"key":"7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Gines","year":"2010","journal-title":"Hepatology"},{"key":"8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2009.01.039","article-title":"Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline","volume":"607","author":"Menani","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s10620-014-3483-x","article-title":"A treat-to-target concept to guide the medical management of hepatorenal syndrome","volume":"60","author":"Zhang","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Wilkes","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12072-011-9269-8","article-title":"Acute kidney injury as a causal factor in mortality associated with hepatorenal syndrome","volume":"5","author":"Golestaneh","year":"2011","journal-title":"Hepatol Int"},{"key":"12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2013.11.032","article-title":"Pseudoephedrine\/ephedrine shows potent anti-inflammatory activity against TNF-alpha-mediated acute liver failure induced by lipopolysaccharide\/D-galactosamine","volume":"724","author":"Yang","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3109\/13880209.2012.685130","article-title":"Hepatoprotective and antioxidant activity of Leucas aspera against D-galactosamine induced liver damage in rats","volume":"50","author":"Balasekar","year":"2012","journal-title":"Pharm Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/2047-783X-16-6-275","article-title":"Dual endothelin-converting enzyme\/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure","volume":"16","author":"Pfab","year":"2011","journal-title":"Eur J Med Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2009.12.031","article-title":"Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats","volume":"631","author":"Pugalendi","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jep.2010.04.019","article-title":"Antioxidant and hepatoprotective effect of swertiamarin from Enicostemma axillare against D-galactosamine induced acute liver damage in rats","volume":"130","author":"Badami","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.fct.2010.03.040","article-title":"Influence of chrysin on hepatic marker enzymes and lipid profile against D-galactosamine-induced hepatotoxicity rats","volume":"48","author":"Pugalendi","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.nephro.2013.05.002","article-title":"[Hepatorenal syndrome: focus]. [Article in French]","volume":"9","author":"Izzedine","year":"2013","journal-title":"Nephrol Ther"},{"key":"19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Gines","year":"2013","journal-title":"J Hepatol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1046\/j.1523-1755.2001.0600031047.x","article-title":"Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat","volume":"60","author":"Nath","year":"2001","journal-title":"Kidney Int"},{"key":"21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03324784","article-title":"Change of expression of renal alpha1-adrenergic receptor and angiotensin II receptor subtypes with aging in rats","volume":"22","author":"Shi","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional alpha1-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10787-009-0027-7","article-title":"Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats","volume":"18","author":"Shafee","year":"2010","journal-title":"Inflammopharmacology"},{"key":"24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11427-014-4672-8","article-title":"Enhanced vasoconstriction to alpha1 adrenoceptor autoantibody in spontaneously hypertensive rats","volume":"57","author":"Liu","year":"2014","journal-title":"Sci China Life Sci"},{"key":"25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1537-1891(02)00337-3","article-title":"andpharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known alpha1-adrenoceptor antagonist","volume":"40","author":"Loza","year":"2003","journal-title":"Vascul Pharmacol"},{"key":"26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/PL00005066","article-title":"Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of alpha1-adrenoceptors in the vas deferens of spontaneously hypertensive rat","volume":"356","author":"Badia","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:26:41Z","timestamp":1589210801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,25]]},"references-count":26,"journal-issue":{"issue":"65","published-print":{"date-parts":[[2017,12,12]]}},"alternative-id":["22668","29312606"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22668","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,25]]}}}